Geoffrey Potts
Position Title
Wayne State University
Associate Professor - Associate Program Director
Clinical Educator - Full-time
Dermatology
Oakland University William Beaumont School of Medicine
Associate Professor, Adjunct
Internal Medicine/Dermatology
Office Location
Wayne Health - Troy
1560 E. Maple Rd.
Troy, MI 48083
Phone: 248-581-5200
Fax: 248-581-5299
Wayne Health - Dearborn
Platinum Medical Center, Suite 290A
5250 Auto Club Dr.
Dearborn, MI 48126
Phone 313-240-4900
Fax 313-429-7992
Community Dermatology Clinic - Detroit
University Health Center, 7A
4201 St. Antoine
Detroit, MI 48201
Phone: 313-822-9801 Option 4
Fax: 313-966-0993
Biography
Dr. Potts specializes in psoriasis, atopic dermatitis, clinical research, hyperhidrosis, medical dermatology, and general dermatology. He graduated from the Wayne State University School of Medicine, completed his internship at St. John Hospital and Medical Center in Detroit, and studied at Saint Louis University Dermatology for a two year research fellowship. He completed his residency with Wayne State University Dermatology and as faculty since 2017 serves now as Associate Program Director in the dermatology program. As of 2024, he is also Adjunct Associate Professor at Oakland University William Beaumont School of Medicine.
He is a member of the American Academy of Dermatology, Dermatology Foundation, American Professors in Dermatology, American Medical Association, Michigan State Medical Society, and the Wayne County Medical Society.
Education Training
Dermatology Residency
Wayne State University, Detroit, MI - 07/2014-06/2017
Dermatology Clinical Research Fellowship
St. Louis University, St. Louis, MO - 07/2012-06/2014
Internal Medicine Preliminary Training
St. John Hospital and Medical Center, Detroit, MI - 07/2011-06/2012
Medical Education
MD, Wayne State University School of Medicine, Detroit, MI - 08/2007-06/2011
Undergraduate
BS in Microbiology, Oakland University, Rochester, MI - 08/2003-05/2007
Areas of Interest
Medical Dermatology, General dermatology, hyperhidrosis, vitiligo, atopic dermatitis, rheumatology-dermatology (connective tissue disease, vasculitis, psoriasis/psoriatic arthritis).
Areas of Research
Hyperhidrosis, vitiligo, psoriasis, atopic dermatitis
Research
CLINICAL TRIALS ACTIVITIES
Wayne State University (7/2014-Present)
Incyte INCB 54707-303: A Phase 3, Randomized, Double-Blind, 52-Week, Placebo-Controlled,
Efficacy and Safety Study of Povorcitinib in Participants With Nonsegmental Vitiligo.
PI Geoffrey Potts. SubI Steven Daveluy. Wayne State Dermatology 1/2024-Current.
Regeneron R668-AD-2217: Phase 4 open Label Single Arm Dupilumab in adolescent and adult skin of
color patients with moderate to severe atopic dermatitis. PI Geoffrey Potts. SubI Steven Daveluy.
Wayne State Dermatology 06/2022-Current.
Pfizer C3941005 Atopic dermatitis and psoriasis topical PDE4 inhibitor. PI Geoffrey Potts.
SubI Steven Daveluy. Wayne State Dermatology 6/2022-5/2023.
Pfizer C2501007 Hidradenitis Suppurativa JAK/TYK inhibitor in adults. PI Steven Daveluy SubI
Geoffrey Potts. Wayne State Dermatology 12/2019-07/2021.
Pfizer B7451015 and B7451037 Atopic Dermatitis JAK inhibitor in adults. PI Geoffrey Potts.
Wayne State Dermatology 3/2019-1/2022.
Pfizer B7451036 Atopic Dermatitis JAK inhibitor in adolescents. Investigator. PI Steven Daveluy.
Wayne State Dermatology 3/2019-1/2020.
Neill B, Chu T, Potts G. Determining patient understanding of commonly used dermatologic terms.
Data collection surveys. . J Am Acad Dermatol. 2020 Sep;83(3):933-935. 05/2018-12/2019.
Detroit Clinical Research Center Galderma subinvestigator, patient recruitment
Nemolizumab Atopic Dermatitis Wayne State Dermatology 12/2017-1/2018. Complete.
Quantificare AbbVie HS/Ps Photo Study Co-PI Wayne State Dermatology 9/2017-04/2020.
Consultant and photographer
(All below Saint Louis University Dept. of Dermatology 7/2012-6/2014)
AMAGINE-1 20120210 (Amgen) Psoriasis trial as subinvestigator with IL-17 antagonist brodalumab. Creating source documents and conducting study visits with patients including photography, PASI, BSA, NAPSI, phlebotomy. PI Maria Yadira Hurley, MD.
A3921079 and extension A3921061 JAK Inhibitor for Psoriasis (Pfizer) Psoriasis trial as subinvestigator with Janus Kinase inhibitor tofacitinib. Conducting study visits with patients including photography, phlebotomy. PI Maria Yadira Hurley, MD.
Basal cell carcinoma Health Outcomes Study with Patient Reported Outcomes (Genentech) PI Scott Fosko, MD. Conducted study visits as subinvestigator with patients enrolling subjects and verifying eligibility
RegiSONIC (Genentech) Conducting enrollment visits ensuring eligibility as subinvestigator under PI Scott Fosko, MD
Bimatoprost for pediatric patients with alopecia (Allergan) Placebo-controlled Allergan trial for eyelash growth under PI Dee Anna Glaser, MD. Conducting study visits as subinvestigator which include photography and global eyelash assessment scoring
Seborrheic dermatitis in African American Women Determining efficacy of ketoconazole foam versus shampoo in African American Women with dandruff. Conducting study visits as subinvestigator with PI Mary Guo, MD
Imiquimod for lentigo maligna PI Scott Fosko, MD. Updating adverse events profiles and determining follow up information from medical records for recurrence. Conducting visits SubI
Study Evaluating Efficacy of Oral Vismodegib in Various Histologic Subtypes with PI Scott Fosko, MD for investigator initiated clinical trial as subinvestigator. Aid in construction of source documents, conducting study visits, photography, phlebotomy, and submitting IND app to FDA
MIKIE Vismodegib Multiple BCC Study (Roche) PI Scott Fosko, MD. Subinvestigator/Photos
Juvéderm Voluma (Allergan) Filler trial as subinvestigator with PI Dee Anna Glaser, MD. Conducting study visits and photography at follow up
Suneva Artefill Filler trial as subinvestigator with PI Dee Anna Glaser, MD. Conducting study visits and photography at follow up
Juvéderm Volbella (Allergan) Lip Filler trial as subinvestigator with PI Dee Anna Glaser, MD. Conducting study visits and photography at follow up
Ulthera Hyperhidrosis Trial (Merz) Conducting study visits and treating patients with axillary hyperhidrosis as subinvestigator with ultrasound Ultherapy device PI Dee Anna Glaser, MD
R668-AD-1021 Atopic Dermatitis (Regeneron) Atopic dermatitis clinical trial as subinvestigator with PI Maria Yadira Hurley, MD. Conducting study visits, phlebotomy, and exams at follow up
Hidradenitis Suppurativa (Astra Zeneca) HS Medi8968 as subinvestigator with PI Maria Yadira Hurley, MD. IL-1 receptor antagonist
Netherton Syndrome topical (Novartis). Pharmacist with PI Elaine Siegfried, MD.
Dermira HH01 Hyperhidrosis topical study Glycopyrrolate wipe study subI with PI D. Glaser, MD.
Dapsone 7.5% topical for acne (Allergan) Subinvestigator conducting study visits, lesion counts, and grading scales with PI Dee Anna Glaser, MD.
ATX-101 Kythera (Allergan) chin fat treatment. Subinvestigator with PI Dee Anna Glaser, MD.
Psoriasis Longitudinal Assessment and Registry (PSOLAR) Janssen study conducting study visits as subinvestigator with PI Maria Yadira Hurley, MD.
ESPRIT Abbott/AbbVie 10-Year observational study to assess long term safety of Humira in adult patients with chronic plaque psoriasis. Subinvestigator with PI Maria Yadira Hurley, MD.
Honors and Awards
Arnold P. Gold Humanism Honor Society at Wayne State University SOM 2024
Wayne State Dermatology Core Faculty of the year 2024, 2023, 2020
Dermatology Interest Group Association Faculty Mentor Award 2022
Wayne State University School of Medicine College Teaching Award 2021
Publications
Reports of Original Work, Reviews, Letter to the Editor
1. Tolliver S, Cascardo C, Wong N, Abushukur Y, Potts G. Dermatology resident comfort level treating hair conditions related to patients with skin of color. Int J Womens Dermatol. 2024 Jun 12;10(2):e137. doi: 10.1097/JW9.0000000000000137. PMID: 38873622.
2. Baiyasi M, St Claire K, Hengy M, Tur K, Fahs F, Potts G. Eyelash serums: A comprehensive review. J Cosmet Dermatol. Published online March 12, 2024. doi:10.1111/jocd.16278. PMID: 38475901.
3. Yousif J, Alkhouri F, St Claire K, Potts G. A practical guide to reducing preoperative and intraoperative patient anxiety in dermatologic surgery. Int J Dermatol. 2023;62(9):1154-1159. doi:10.1111/ijd.16802. PMID: 37529942.
4. Abdelnour A, Adlam T, Potts GA. Effects of Plant-Derived Dietary Supplements on Skin Health: A Review. Cureus. 2023;15(6):e40892. Published 2023 Jun 24. doi:10.7759/cureus.40892. PMID: 37492817.
5. Wong N, Cascardo CA, Mansour M, Qian V, Potts GA. A Review of Pityriasis Rosea in Relation to SARS-CoV-2/COVID-19 Infection and Vaccination. Cureus. 2023;15(5):e38772. Published 2023 May 9. doi:10.7759/cureus.38772. PMID: 37303403.
6. Bardhi R, Musa A, Daveluy S, Potts G. Sophomore Signaling: The Second Year of the ERAS Supplemental Application for Dermatology Residency. J Clin Aesthet Dermatol. 2023 Apr;16(4):26-27. PMID: 37077929.
7. Wong N, Williams K, Tolliver S, Potts GA. Hair length in association with hair care regimen and healthy habits in Black women. J Cosmet Dermatol. 2023;22(8):2361-2363. doi:10.1111/jocd.15696. PMID: 36994547.
8. Parashar K, Adlam T, Potts G. The Impact of Hyperhidrosis on Quality of Life: A Review of the Literature. Am J Clin Dermatol. 2023;24(2):187-198. doi:10.1007/s40257-022-00743-7 PMID: 36622502.
9. Wong NS, Adlam TM, Potts GA, Farshchian M. Hyperhidrosis: A Review of Recent Advances in Treatment with Topical Anticholinergics. Dermatol Ther (Heidelb). 2022;12(12):2705-2714. doi:10.1007/s13555-022-00838-3 PMID: 36329359.
10. Abushukur Y, Oska S, Nartker N, Fahs F, Potts G. Women representation in dermatology residency program leadership: A cross-sectional study. Int J Womens Dermatol. 2022;8(3):e045. Published 2022 Aug 26. doi:10.1097/JW9.0000000000000045. PMID: 36035863.
11. Mansour MR, Abushukur Y, Potts GA. Keratosis Pilaris on TikTok: A Cross-Sectional Analysis of Trending Content. JAAD Int. 2022 Jun 22; 8:116-117. doi: 10.1016/j.jdin.2022.06.015. PMID: 35875398.
12. Osto M, Farshchian M, Alnabolsi A, Smidi SA, Baiyasi M, Potts GA. Aluminum-containing antiperspirants are not associated with breast cancer. J Cosmet Dermatol. 2022;21(10):5244-5245. doi:10.1111/jocd.14796. PMID: 35073435.
13. Rehman R, Shareef SJ, Mohammad TF, Potts G, Fahs F. Comment and Controversy Edited by Stephen P. Stone, MD Applying to Dermatology Residency without a Home Program: Advice to Medical Students in COVID-19 Pandemic and Beyond. Clin Dermatol. 2022;S0738-081X(22)00047-5. doi: 10.1016/j.clindermatol.2022.01.003. PMID 35248689.
14. Osto M, Smidi SA, Alnabolsi A, Rehman R, Potts G. An evidence-based approach for malignancy-associated and paraneoplastic generalized granuloma annulare. J Am Acad Dermatol. 2022;87(4):876-878. doi:10.1016/j.jaad.2021.11.051. PMID: 34875306.
15. Nasser S, Farshchian M, Kimyai-Asadi A, Potts GA. Techniques to Relieve Pain Associated With Botulinum Injections for Palmar and Plantar Hyperhidrosis. Dermatol Surg. 2021;47(12):1566-1571. doi:10.1097/DSS.0000000000003182. PMID: 34743126.
16. Enescu CD, Bedford LM, Potts G, Fahs F. A review of topical vitamin C derivatives and their efficacy. J Cosmet Dermatol. 2022;21(6):2349-2359. doi:10.1111/jocd.14465 PMID: 34559950.
17. Yousif J, Farshchian M, Potts GA. Oral nail growth supplements: a comprehensive review. Int J Dermatol. 2022;61(8):916-922. doi:10.1111/ijd.15807. PMID 34351622.
18. Nasser S, Musa A, Yousif J, Warbasse E, Potts G. Pre-Procedural Patient Anxiety in Dermatologic Procedures: A Cross-Sectional Study of Dermatologists. Austin J Dermatolog; 2021; 8(1): 1097.
19. Liu V, Farshchian M, Potts GA. Management of primary focal hyperhidrosis: An algorithmic approach. J Drugs Dermatol. 2021 May 1;20(5):523-528. doi: 10.36849/JDD.5774. PMID: 33938689.
20. Potts GA, Adlam T, Stierman SC, Moossavi M, Mehregan D. Pleomorphic Fibroma: A Clinicopathologic Case Series With the Review of the Literature. Am J Dermatopathol. 2021;43(8):560-566. doi:10.1097/DAD.0000000000001879 PMID: 33534206.
21. Adelman MJ, Bedford LM, Potts GA. Clinical efficacy of popular oral hair growth supplement ingredients. Int J Dermatol. 2021;60(10):1199-1210. doi:10.1111/ijd.15344 PMID:33296077.
22. Farshchian M, Potts G, Kimyai-Asadi A, Mehregan D, Daveluy S. Outpatient Teledermatology Implementation During the COVID-19 Pandemic: Challenges and Lessons Learned. J Drugs Dermatol. 2020 Jun 1;19(6):683. PMID: 32574014.
23. Neill BC, Golda N, Seger EW, Wick J, Whitsitt J, Huber A, Chu T, Potts GA, Chow P, Moore S, Fakhoury JW, Rajpara A, Hocker TLH. Determining patient understanding of commonly used dermatology terms: A multicenter cross-sectional survey. J Am Acad Dermatol. 2020;83(3):933-935. doi:10.1016/j.jaad.2020.01.016. PMID: 31958524.
24. Fosko S, Chu MB, Armbrecht E, Galperin T, Potts GA, Mattox A, Kurta A, Polito K, Slutsky J, Burkemper NM, Hurley MY. Fosko SW, Chu MB, Armbrecht E, et al. Efficacy, rate of tumor response, and safety of a short course (12-24 weeks) of oral vismodegib in various histologic subtypes (infiltrative, nodular, and superficial) of high-risk or locally advanced basal cell carcinoma, in an open-label, prospective case series clinical trial. J Am Acad Dermatol. 2020;82(4):946-954. doi:10.1016/j.jaad.2019.12.002. PMID: 31836564.
Case Reports
1. St Claire K, Edriss M, Potts GA. Cutaneous Rosai-Dorfman Disease: A Case Report. Cureus. 2023;15(5):e39617. Published 2023 May 28. doi:10.7759/cureus.39617. PMID: 37388601.
2. Wong N, King AD, Potts GA. Successful Treatment of Refractory Hailey-Hailey Disease with Dupilumab: A Case Report. SKIN J Cutan Med. 2023;7(2):736-739 Published 2023 Mar. doi:https://doi.org/10.25251/skin.7.2.15.
3. Alkhouri F, Alkhouri S, Potts GA. Prurigo Pigmentosa Following a Keto Diet and Bariatric Surgery. Cureus. 2022;14(4):e24307. Published 2022 Apr 20. doi:10.7759/cureus.24307. PMID: 35602831.
4. Messenger N, Messenger G, Potts G. Pustular rash masking Kawasaki disease [published online ahead of print, 2022 Mar 13]. Int J Dermatol. 2022;10.1111/ijd.16154. doi:10.1111/ijd.16154. PMID: 35279824.
5. Rehman R, St Claire K, Fahs F, Potts G. Intradermal progesterone testing for autoimmune progesterone dermatitis. Int J Dermatol. 2023;62(5):e287-e288. doi:10.1111/ijd.16140. PMID: 35220588.
6. Farshchian M, Potts GA. Transient hypertriglyceridaemia associated with propranolol for treatment of infantile hemangioma. Australas J Dermatol. 2021;62(4):e580-e581. doi:10.1111/ajd.13669. PMID: 34293182.
7. Oska S, Bedford LM, Potts GA. Alopecia totalis following hand-foot-and-mouth disease. Pediatr Dermatol. 2021;38(3):640-642. doi:10.1111/pde.14550. PMID 33650159.
8. Horton L, Fahs F, Jain A, Potts G. An eruption of numerous spiny papules in a pediatric transplant patient. Am J Transplant. 2020;20(12):3688-3690. doi:10.1111/ajt.16294. PMID:33264504.
Book Authorships, Editorships, and Chapters
1. Jensen R, Potts G. Stage 4 Faculty guide: Transition to senior resident. In Lamb S, Rajasekaran SK. Facilitating Effective Transitions Along the Medical Education Continuum: A Handbook for Learners and Faculty Derived from Corporate Coaching; 2021.
2. Tutag Lehr V, Potts G, Lulic-Botica M. Pediatric Topical Medications. In Aranda JV, Vande Anker J, eds. Pediatric Pharmacology: Therapeutic Principles in Practice. 5th ed. Philadelphia, PA: Lippincott, Williams & Wilkins; Nov 5, 2020.
3. Potts G, Hurley MY. Psoriasis in the Geriatric Population. Clin Geriatr Med. 2013 May;29(2): 373-95. doi: 10.1016/j.cger.2013.01.004. PMID: 23571034.